Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies.
Heinrich MC, Zhang X, Jones RL, George S, Serrano C, Deng Y, Bauer S, Cai S, Wu X, Zhou Y, Tao K, Zheng Z, Zhang J, Cui Y, Cao H, Wang M, Hu J, Yang J, Li J, Shen L.
Heinrich MC, et al. Among authors: zhang j, zhang x.
Clin Cancer Res. 2024 Feb 16;30(4):719-728. doi: 10.1158/1078-0432.CCR-23-1861.
Clin Cancer Res. 2024.
PMID: 38032349
Clinical Trial.